Association of Sleep Duration with Cardiovascular Disease Risk in Type 2 Diabetes Patients: Analysis Using Different Models. by Zhi Jin (3742471)

Subjects:

Flow Chart of Study Participant Selection. by Zhi Jin (3742471)

Subjects:

Linear relationship between sleep duration and cardiovascular disease (CVD) risk in type 2 diabetes patients. by Zhi Jin (3742471)

Subjects:

(a) Lactate suppression by sequential re-insertion of cmpd at low concentration in Jurkat cells. by Samo Lešnik (21073880)

Half maximal inhibitory concentrations (IC₅₀) of selected compounds. by Samo Lešnik (21073880)

<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate.... by Atefeh Sadeghi (21253051)

“…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”

Distribution of continuous variables of all 3 visits (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as mea... by Nattapon Riengvirodkij (11268720)

Two magnifications SEM images for the produced SiO₂ nanoparticles. by Nasser A. M. Barakat (11705885)

Subjects:

Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells. by Farshid Maleki (20521649)

Subjects:

XRD pattern for the prepared titanium oxide nanofibers. by Nasser A. M. Barakat (11705885)

Subjects:

Plasticity limit (%) of pristine and modified Egyptian kaolin. by Nasser A. M. Barakat (11705885)

Subjects:

Thermal gravimetric analyses and the first derivative for the obtained data for the PVA; (A and B) and TiO₂; (C and D) compared with the pristine kaolin. by Nasser A. M. Barakat (11705885)

Subjects:

Chemical composition (%) of the Egyptian clay [9]. by Nasser A. M. Barakat (11705885)

Subjects:

Compression strength of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. by Nasser A. M. Barakat (11705885)

Subjects:

Two magnifications SEM; (A and B) and TEM (C and D) images for the produced TiO₂ nanofibers. by Nasser A. M. Barakat (11705885)

Subjects:

Apparent density of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. by Nasser A. M. Barakat (11705885)

Subjects:

Water absorption of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. by Nasser A. M. Barakat (11705885)

Subjects:

Trypan blue dye exclusion assay for cell viability evaluation (% of control). by Farshid Maleki (20521649)

Subjects:

Percentage change in the apparent density of pristine and modified Egyptian kaolin sintered at 1050 °C for 4 successive cycles. by Nasser A. M. Barakat (11705885)

Subjects:

Porosity of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. by Nasser A. M. Barakat (11705885)

Subjects: